Advances in immunotoxins

T N Oeltmann1, A E Frankel

  • 1Department of Medicine, Vanderbilt Medical School, Nashville, Tennessee 37232.

Summary

Immunotoxin research is expanding, with significant advances in molecular biology and clinical applications. Future work will focus on peptide toxin mechanisms and targeted toxin design for treating human diseases.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...